Loading clinical trials...

Safety of Endoscopic Thyroidectomy Via Retro-Auricular Single-Site Approach, Transoral Approach and Transareola | Clinical Trials | Clareo Health

COMPLETEDNA

Safety of Endoscopic Thyroidectomy Via Retro-Auricular Single-Site Approach, Transoral Approach and Transareola

Single-center, Retrospective Study of Retro-Auricular Single-Site Endoscopic, Transoral Endoscopic Thyroidectomy Vestibular Approach and Transareola Endoscopic Thyroidectomy in Patients With Early Stage Papillary Thyroid Carcinoma

NCT05760690•Sun Yat-sen University

View on ClinicalTrials.gov

Summary

The goal of this retrospective study is to compare the safety and efficiacy of endoscopic thyroidectomy via retro-auricular single-site approach, transoral endoscopic thyroidectomy vestibular approach and transareola approach.

Eligibility

Age

18 - 70 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•1. Age 18-70 years old, no gender restrictions.
•2. Fine-needle aspiration cytology(FNA) confirmed papillary thyroid carcinoma(PTC).
•3. Early stage PTC (stage T1N0M0).
•4. Preoperative ultrasonography showed unilateral glandular lobe malignant tumor and the largest diameter was not more than 2cm, without cervical lymph node metastasis and extensive metastasis.
•5. Patients undergoing thyroid lobectomy and central lymph node dissection.
•6. Patients who have signed an approved Informed Consent.

Exclusion Criteria

•1. Patients who do not accept case data collection for various reasons.
•2. The clinical data unfit this study (at the discretion of the investigator).
•3. Patients who have undergone neck surgery or radiotherapy before this trail.
•4. Patients who have uncontrolled hyperthyroidism.

Locations (1)

Sun Yat-Sen University Cancer Center

Guangzhou, Guangdong, China

Key Dates

Start Date

January 1, 2015

Primary Completion Date

December 1, 2024

Completion Date

December 1, 2024

Last Updated

December 3, 2024

Enrollment

160

ACTUAL participants

Conditions

Papillary Thyroid Carcinoma

Interventions

Retro-Auricular Single-Site Endoscopic Thyroidectomy

PROCEDURE

Transoral Endoscopic Thyroidectomy Vestibular Approach

PROCEDURE

Transareola Endoscopic Thyroidectomy

PROCEDURE

Active Surveillance and Surgery Outcomes in Low Risk Papillary Thyroid Cancer

NCT04624477

Papillary Thyroid CancerPapillary Thyroid Carcinoma+1 more

View study

ACTIVE_NOT_RECRUITING

Diagnostic Accuracy of Fluorodeoxyglucose-18 PET in the Evaluation of RPTC With Patient's Raised Thyroglobulin Level

NCT07062211

Papillary Thyroid Carcinoma

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 3, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Safety of Endoscopic Thyroidectomy Via Retro-Auricular Single-Site Approach, Transoral Approach and Transareola

Inclusion Criteria

Exclusion Criteria

Active Surveillance and Surgery Outcomes in Low Risk Papillary Thyroid Cancer

Diagnostic Accuracy of Fluorodeoxyglucose-18 PET in the Evaluation of RPTC With Patient's Raised Thyroglobulin Level

Is Routine Dissection of Central Lymph Node Necessary for Papillary Thyroid Carcinoma, T1-2 N0?